Although desmoid tumors do not metastasize, they can be associated with recurrence rates of up to 77% after surgical resection. 6,9 Desmoid tumor experts and treatment guidelines now recommend ...

The FDA has expanded the label for oral semaglutide (Rybelsus; Novo Nordisk) tablets 7 mg and 14 mg to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who ...

An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical ...

A quiet revolution is underway in hair loss treatment with oral minoxidil. Once a blood pressure medication, low-dose oral ...

Disc Medicine earns a Strong Buy rating as bitopertin advances for EPP/XLP, with FDA review fast-tracked and strong funding.

Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...

Digital biomarkers have advanced from pilots into assets that can change development decisions if they are built, validated and governed with purpose. This webinar convenes leaders from academia and ...

New data from OASIS 4 on oral semaglutide 25 mg to reveal insights on cardiometabolic health among adults with obesity or overweight Additional trial ...

New data from OASIS 4 on oral semaglutide 25 mg to reveal insights on cardiometabolic health among adults with obesity or overweight Additional trial insights ...

Sanofi’s teplizumab, which is already FDA-approved to delay the onset of stage 3 type 1 diabetes, has been included on the ...

These Phase III results could enhance uptake of Eli Lilly's Verzenio alongside ET in the adjuvant breast cancer setting, if ...

Learn how accelerating drug discovery is reshaping the pathway from lab findings to effective therapies with real-world data.